Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Li, Shujing ^a   Wang, Xianyun ^a   Li, Jing ^a   Zhang, Jun ^a   Zhang, Fan ^a   Hu, Jie ^a   Qi, Yixin ^a   Yan, Baoyong ^a   Li, Quanhai ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; APOPTOSIS; BLOOD OXYGEN TENSION; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; DIABETIC FOOT; DRUG ADMINISTRATION ROUTE; HEART MUSCLE REPERFUSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIC CARDIOMYOPATHY; MESENCHYMAL STEM CELL TRANSPLANTATION; META ANALYSIS (TOPIC); MICROENVIRONMENT; NEUROPROTECTION; NONHUMAN; PARACRINE SIGNALING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

EID: 84973402529     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/5896061     Document Type: Review

References (91)

1. A. J. Friedenstein, K. V. Petrakova, A. I. Kurolesova, G. P. Frolova, "Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues," Transplantation, vol. 6, no. 2, pp. 230-247, 1968.
2. I. N. Simões, J. S. Boura, F. dos Santos et al., "Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media," Biotechnology Journal, vol. 8, no. 4, pp. 448-458, 2013.
3. N. Xiong, Z. Zhang, J. Huang et al., "VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease," GeneTherapy, vol. 18, no. 4, pp. 394-402, 2011.
4. J. Deng, Z.-M. Zou, T.-L. Zhou et al., "Bone marrow mesenchymal stemcells can bemobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue," Neurological Sciences, vol. 32, no. 4, pp. 641-651, 2011.
5. C. P. Hodgkinson, J. A. Gomez, M. Mirotsou, V. J. Dzau, "Genetic engineering of mesenchymal stem cells and its application in human disease therapy," Human GeneTherapy, vol. 21, no. 11, pp. 1513-1526, 2010.
6. P.-M. Chen, M.-L. Yen, K.-J. Liu, H.-K. Sytwu, B.-L. Yen, "Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells," Journal of Biomedical Science, vol. 18, article 49, 2011.
7. P. Bianco, P. G. Robey, P. J. Simmons, "Mesenchymal stem cells: revisiting history, concepts, assays," Cell Stem Cell, vol. 2, no. 4, pp. 313-319, 2008.
8. G. Cavallari, E. Olivi, F. Bianchi et al., "Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissuederived stem cells preconditioned with natural molecules," Cell Transplantation, vol. 21, no. 12, pp. 2771-2781, 2012.
9. Y. Zhang, W. Shen, J. Hua et al., "Pancreatic islet-like clusters from bone marrow mesenchymal stem cells of human firsttrimester abortus can cure streptozocin-induced mouse diabetes," Rejuvenation Research, vol. 13, no. 6, pp. 695-706, 2010.
10. S. Kadam, S. Muthyala, P. Nair, R. Bhonde, "Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes," The Review of Diabetic Studies, vol. 7, no. 2, pp. 168-182, 2010.
11. R. Anzalone,M. Lo Iacono, T. Loria et al., "Wharton's jellymesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes," Stem Cell Reviews and Reports, vol. 7, no. 2, pp. 342-363, 2011.
12. H.-Y. Li, Y.-J. Chen, S.-J. Chen et al., "Induction of insulinproducing cells derived from endometrial mesenchymal stemlike cells," The Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 3, pp. 817-829, 2010.
13. H.-S. Wang, J.-F. Shyu, W.-S. Shen et al., "Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice," Cell Transplantation, vol. 20, no. 3, pp. 455-466, 2011.
14. R. F. El-Demerdash, L. N. Hammad, M. M. Kamal, H. O. ElMesallamy, "A comparison of Wharton's jelly and cord blood as a source ofmesenchymal stem cells for diabetes cell therapy," Regenerative Medicine, vol. 10, no. 7, pp. 841-855, 2015.
15. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999.
16. T. C. Mackenzie and A. W. Flake, "Multilineage differentiation of humanMSC after in utero transplantation," Cytotherapy, vol. 3, no. 5, pp. 403-405, 2001.
17. O. Honmou, K. Houkin, T. Matsunaga et al., "Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke," Brain, vol. 134, part 6, pp. 1790-1807, 2011.
18. J. S. Lee, J. M. Hong, G. J. Moon et al., "A long-term followup study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke," STEM CELLS, vol. 28, no. 6, pp. 1099-1106, 2010.
19. T. I. G. van der Spoel, S. J. Jansenof Lorkeers, P. Agostoni et al., "Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease," Cardiovascular Research, vol. 91, no. 4, pp. 649-658, 2011.
20. A. O'Loughlin, M. Kulkarni, M. Creane et al., "Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer," Diabetes, vol. 62, no. 7, pp. 2588-2594, 2013.
21. D. Lu, B. Chen, Z. Liang et al., "Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial," Diabetes Research and Clinical Practice, vol. 92, no. 1, pp. 26-36, 2011.
22. C. Stapf and J. P. Mohr, "Ischemic stroke therapy," Annual Review of Medicine, vol. 53, pp. 453-475, 2002.
23. K. Shinozuka, T. Dailey,N. Tajiri et al., "Stem cells for neurovascular repair in stroke," Journal of StemCell Research&Therapy, vol. 4, no. 4, Article ID 12912, 2013.
24. C. Chen, Y. Wang, G.-Y. Yang, "Stem cell-mediated gene delivering for the treatment of cerebral ischemia: progress and prospectives," Current Drug Targets, vol. 14, no. 1, pp. 81-89, 2013.
25. X. Ding, Y. Li, Z. Liu et al., "The sonic hedgehog pathway mediates brain plasticity and subsequent functional recovery after bone marrow stromal cell treatment of stroke in mice," Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 7, pp. 1015-1024, 2013.
26. S. Du, J. Guan, G. Mao et al., "Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats," Cell Transplantation, vol. 23, supplement 1, pp. 73-82, 2014.
27. W. Jiang, G. Liang, X. Li et al., "Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAo," Journal of Materials Science. Materials in Medicine, vol. 25, no. 5, pp. 1357-1366, 2014.
28. X.-L. Liu, W. Zhang, S.-J. Tang, "Intracranial transplantation of human adipose-derived stem cells promotes the expression of neurotrophic factors and nerve repair in rats of cerebral ischemia-reperfusion injury," International Journal of Clinical and Experimental Pathology, vol. 7, no. 1, pp. 174-183, 2014.
29. L.-Q. Wang, Z.-Z. Lin, H.-X. Zhang et al., "Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke," CNS Neuroscience & Therapeutics, vol. 20, no. 4, pp. 317-326, 2014.
30. Y. Zhu, Y.-M. Guan, H.-L. Huang, Q.-S. Wang, "Human umbilical cord blood mesenchymal stem cell transplantation suppresses inflammatory responses and neuronal apoptosis during early stage of focal cerebral ischemia in rabbits," Acta Pharmacologica Sinica, vol. 35, no. 5, pp. 585-591, 2014.
31. T. N. Chung, J. H. Kim, B. Y. Choi, S. P. Chung, S. W. Kwon, S. W. Suh, "Adipose-derivedmesenchymal stem cells reduce neuronal death after transient global cerebral ischemia through prevention of blood-brain barrier disruption and endothelial damage," Stem Cells Translational Medicine, vol. 4, no. 2, pp. 178-185, 2015.
32. N. Gu, C. Rao, Y. Tian et al., "Anti-inflammatory and antiapoptotic effects of mesenchymal stem cells transplantation in rat brain with cerebral ischemia," Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 10, pp. 2598-2606, 2014.
33. G. Tang, Y. Liu, Z. Zhang et al., "Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia," Stem Cells, vol. 32, no. 12, pp. 3150-3162, 2014.
34. B. Chelluboina, J. D. Klopfenstein, D. M. Pinson, D. Z. Wang,K. K. Veeravalli, "Stemcell treatment after cerebral ischemia regulates the gene expression of apoptotic molecules," Neurochemical Research, vol. 39, no. 8, pp. 1511-1521, 2014.
35. V. A. Babenko,D. N. Silachev, L. D. Zorova et al., "Improving the post-stroke therapeutic potency of mesenchymal multipotent stromal cells by cocultivation with cortical neurons: the role of crosstalk between cells," Stem Cells Translational Medicine, vol. 4, no. 9, pp. 1011-1020, 2015.
36. W. Huang, B. Lv, H. Zeng et al., "Paracrine factors secreted by MSCs promote astrocyte survival associated with GFAP downregulation after ischemic stroke via p38 MAPK and JNK," Journal of Cellular Physiology, vol. 230, no. 10, pp. 2461-2475, 2015.
37. X. Bao, J. Wei, M. Feng et al., "Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats," Brain Research, vol. 1367, pp. 103-113, 2011.
38. C.-M. Liang, S.-J. Weng, T.-H. Tsai et al., "Neurotrophic and neuroprotective potential of human limbus-derived mesenchymal stromal cells," Cytotherapy, vol. 16, no. 10, pp. 1371-1383, 2014.
39. P. Huang, N. Gebhart, E. Richelson, T. G. Brott, J. F. Meschia, A. C. Zubair, "Mechanism of mesenchymal stem cellinduced neuron recovery and anti-inflammation," Cytotherapy, vol. 16, no. 10, pp. 1336-1344, 2014.
40. H. Shichinohe, T. Ishihara, K. Takahashi et al., "Bone marrow stromal cells rescue ischemic brain by trophic effects and phenotypic change toward neural cells,"Neurorehabilitation and Neural Repair, vol. 29, no. 1, pp. 80-89, 2015.
41. E. Déz-Tejedor, M. Gutiérrez-Fernández, P. Martnez-Sánchez et al., "Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells fromadipose tissue: a safety assessment: a phase II randomized, double-blind, placebocontrolled, single-center, pilot clinical trial," Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 10, pp. 2694-2700, 2014.
42. A. Zacharek, A. Shehadah, J. Chen et al., "Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment," Stroke, vol. 41, no. 3, pp. 524-530, 2010.
43. R. E. Michler, "Stem cell therapy for heart failure," Methodist DeBakey Cardiovascular Journal, vol. 9, no. 4, pp. 187-194, 2013.
44. M. Gnecchi, P. Danieli, E. Cervio, "Mesenchymal stem cell therapy for heart disease," Vascular Pharmacology, vol. 57, no. 1, pp. 48-55, 2012.
45. S. L. Chen, W. W. Fang, J. Qian et al., "Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction," Chinese Medical Journal, vol. 117, no. 10, pp. 1443-1448, 2004.
46. J. M. Hare, J. H. Traverse, T. D. Henry et al., "A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction," Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277-2286, 2009.
47. A. R. Williams, B. Trachtenberg, D. L. Velazquez et al., "Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling," Circulation Research, vol. 108, no. 7, pp. 792-796, 2011.
48. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., "Comparison of allogeneic vs autologous bonemarrow-derivedmesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial," The Journal of the AmericanMedical Association, vol. 308, no. 22, pp. 2369-2379, 2012.
49. D. W. Losordo, T. D. Henry, C. Davidson et al., "Intramyocardial, autologous CD34+ cell therapy for refractory angina," Circulation Research, vol. 109, no. 4, pp. 428-436, 2011.
50. A. W. Heldman, D. L. DiFede, J. E. Fishman et al., "Transendocardialmesenchymal stem cells and mononuclear bonemarrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial," The Journal of the American Medical Association, vol. 311, no. 1, pp. 62-73, 2014.
51. S. Daniel, M. Robert, V. Lo Cicero et al., "Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function," Circulation, vol. 127, no. 19, pp. 1968-1979, 2013.
52. J. H. Traverse, T. D. Henry, C. J. Pepine et al., "Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial," The Journal of the American Medical Association, vol. 308, no. 22, pp. 2380-2389, 2012.
53. S. Zhang, A. Sun, D. Xu et al., "Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials," Clinical Cardiology, vol. 32, no. 8, pp. 458-466, 2009.
54. R. R. Makkar, M. J. Price, M. Lill et al., "Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model ofmyocardial infarction," Journal of Cardiovascular Pharmacology andTherapeutics, vol. 10,no. 4, pp. 225-233, 2005.
55. Y.-J. Yang, H.-Y. Qian, J. Huang et al., "Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts," Arteriosclerosis, Thrombosis, Vascular Biology, vol. 29,no. 12, pp. 2076-2082, 2009.
56. H. C. Quevedo, K. E. Hatzistergos, B. N. Oskouei et al., "Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 14022-14027, 2009.
57. X. Teng, L. Chen,W. Chen, J. Yang,Z. Yang,Z. Shen, "Mesenchymal stem cell-derived exosomes improve the microenvironment of infarctedmyocardium contributing to angiogenesis and anti-inflammation," Cellular Physiology and Biochemistry, vol. 37, no. 6, pp. 2415-2424, 2015.
58. E. S. Zubkova, I. B. Beloglazova, P. I. Makarevich et al., "Regulation of adipose tissue stem cells angiogenic potential by tumor necrosis factor-alpha," Journal of Cellular Biochemistry, vol. 117, no. 1, pp. 180-196, 2016.
59. Z. Wen, W. Huang, Y. Feng et al., "MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF," PLoS ONE, vol. 9, no. 9, Article ID e104666, 2014.
60. R. A. Boomsma and D. L. Geenen, "Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis," PLoS ONE, vol. 7, no. 4, Article ID e35685, 2012.
61. J.-W. Lee, S.-H. Lee, Y.-J. Youn et al., "A randomized, openlabel, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction," Journal of KoreanMedical Science, vol. 29, no. 1, pp. 23-31, 2014.
62. X. Wang, W.-C. Xi, F. Wang, "The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction," Biotechnology Letters, vol. 36, no. 11, pp. 2163-2168, 2014.
63. S. A. Fisher, S. J. Brunskill, C. Doree, A. Mathur, D. P. Taggart, E. Martin-Rendon, "Stemcell therapy for chronic ischaemic heart disease and congestive heart failure," Cochrane Database of Systematic Reviews, no. 4, Article ID CD007888, 2014.
64. S. A. Fisher, C. Doreé, S. J. Brunskill, A. Mathur, E. Martin-Rendon, "Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: a systematic review and meta-analysis," PLoS ONE, vol. 8, no. 6, Article ID e64669, 2013.
65. A. N. Nowbar, M. Mielewczik, M. Karavassilis et al., "Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis," British Medical Journal, vol. 348, Article ID g2688, 2014.
66. S. Chen, J. Shi, M. Zhang et al., "Mesenchymal stem cell-laden anti-inflammatory hydrogel enhances diabetic wound healing," Scientific Reports, vol. 5, article 18104, 2015.
67. J. Kato, H. Kamiya, T. Himeno et al., "Mesenchymal stem cells ameliorate impaired wound healing through enhancing keratinocyte functions in diabetic foot ulcerations on the plantar skin of rats," Journal of Diabetes and Its Complications, vol. 28, no. 5, pp. 588-595, 2014.
68. L. Shen, W. Zeng, Y.-X. Wu et al., "Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells," Cell Transplantation, vol. 22, no. 6, pp. 1011-1021, 2013.
69. C. Tong, H. Hao, L. Xia et al., "Hypoxia pretreatment of bone marrow-derived mesenchymal stem cells seeded in a collagen-chitosan sponge scaffold promotes skinwound healing in diabetic rats with hindlimb ischemia," Wound Repair and Regeneration, vol. 24, no. 1, pp. 45-56, 2016.
70. H. C. Lee, S. G. An,H. W. Lee et al., "Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study," Circulation Journal, vol. 76, no. 7, pp. 1750-1760, 2012.
71. H. K. Kim, Y. J. Kim, J. T. Kim et al., "Alterations in the proangiogenic functions of adipose tissue-derived stromal cells isolated fromdiabetic rats," Stem Cells and Development, vol. 17, no. 4, pp. 669-680, 2008.
72. Y. Wang, Q. Q. Dan, Q. P. Wang et al., "Human umbilic mesenchymal stromal cells repairs diabetic foot in rats associated with VEGF expressional change," Journal of Sichuan University. Medical Science Edition, vol. 45, no. 1, pp. 29-33, 2014.
73. H.-J. You, S. Namgoong, S.-K. Han, S.-H. Jeong, E.-S. Dhong,W.-K. Kim, "Wound-healing potential of human umbilical cord blood-derived mesenchymal stromal cells in vitro-a pilot study," Cytotherapy, vol. 17, no. 11, pp. 1506-1513, 2015.
74. N. Xia, J.-M. Xu, N. Zhao, Q.-S. Zhao, M. Li, Z.-F. Cheng, "Human mesenchymal stem cells improve the neurodegeneration of femoral nerve in a diabetic foot ulceration rats," Neuroscience Letters, vol. 597, pp. 84-89, 2015.
75. J. H. Ho, T.-C. Tseng, W.-H. Ma et al., "Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and-cell differentiation in streptozocin-induced diabetic mice," Cell Transplantation, vol. 21, no. 5, pp. 997-1009, 2012.
76. S. Zonta, M. De Martino, G. Bedino et al., "Which Is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial" Transplantation Proceedings, vol. 42, no. 4, pp. 1336-1340, 2010.
77. C. Nie, D. Yang, J. Xu, Z. Si, X. Jin, J. Zhang, "Locally administered adipose-derived stemcells acceleratewound healing through differentiation and vasculogenesis," Cell Transplantation, vol. 20, no. 2, pp. 205-216, 2011.
78. A. Schiavetta, C. Maione, C. Botti et al., "Aphase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of theNaples and Pietra Ligure evaluation of stem cells study," Stem Cells TranslationalMedicine, vol. 1, no. 7, pp. 572-578, 2012.
79. S. Maxson, E. A. Lopez, D. Yoo, A. Danilkovitch-Miagkova, M. A. Leroux, "Concise review: role of mesenchymal stem cells in wound repair," Stem Cells Translational Medicine, vol. 1, no. 2, pp. 142-149, 2012.
80. E. J. Marrotte, D.-D. Chen, J. S. Hakim, A. F. Chen, "Manganese superoxide dismutase expression in endothelial progenitor cells accelerateswound healing in diabetic mice,"The Journal of Clinical Investigation, vol. 120, no. 12, pp. 4207-4219, 2010.
81. D. R. Whiting, L. Guariguata, C. Weil, J. Shaw, "IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030," Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311-321, 2011.
82. P. Walczak, J. Zhang, A. A. Gilad et al., "Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia," Stroke, vol. 39, no. 5, pp. 1569-1574, 2008.
83. M. Mouiseddine, S. François, M. Souidi, A. Chapel, "Intravenous humanmesenchymal stem cells transplantation in NOD/SCID mice preserve liver integrity of irradiation damage," Methods in Molecular Biology, vol. 826, pp. 179-188, 2012.
84. S. K. Kang, I. S. Shin, M. S. Ko, J. Y. Jo, J. C. Ra, "Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stemcell therapy," Stem Cells International, vol. 2012, Article ID342968, 11 pages, 2012.
85. A. Stolzing, D. Sellers, O. Llewelyn, A. Scutt, "Diabetes induced changes in rat mesenchymal stem cells," Cells Tissues Organs, vol. 191, no. 6, pp. 453-465, 2010.
86. W. Wang, X. Zhang, J. Zheng, J. Yang, "High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signalregulated kinase pathway,"Molecular and Cellular Biochemistry, vol. 338, no. 1-2, pp. 115-122, 2010.
87. E. A. Silva, E.-S. Kim, J. K. Hyun, D. J. Mooney, "Materialbased deployment enhances efficacy of endothelial progenitor cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14347-14352, 2008.
88. J. H. Kim, S.-H. Park, S. G. Park, J.-S. Choi, Y. Xia, J.-H. Sung, "The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells," Stem Cells and Development, vol. 20, no. 10, pp. 1753-1761, 2011.
89. R. Das, H. Jahr, G. J. V. M. van Osch, E. Farrell, "The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches," Tissue Engineering Part B: Reviews, vol. 16, no. 2, pp. 159-168, 2010.
90. M. Nagano, K. Kimura,T. Yamashita et al., "Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair," Stem Cells andDevelopment, vol. 19, no. 8, pp. 1195-1210, 2010.
91. J. Vojtassák, L. Danisovic, M. Kubes et al., "Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot," Neuro Endocrinology Letters, vol. 27, supplement 2, pp. 134-137, 2006.